These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4010344)

  • 1. Animal models of multiple sclerosis.
    Fleming JO
    Mayo Clin Proc; 1985 Jul; 60(7):490-2. PubMed ID: 4010344
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology and etiology in multiple sclerosis: a review.
    Kraft AM; Wessman HC
    Phys Ther; 1974 Jul; 54(7):716-20. PubMed ID: 4608763
    [No Abstract]   [Full Text] [Related]  

  • 3. A Therapeutic Link between Astrogliosis and Remyelination in a Mouse Model of Multiple Sclerosis.
    Pearson C
    J Neurosci; 2018 Jan; 38(1):29-31. PubMed ID: 29298907
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model.
    Romanelli E; Merkler D; Mezydlo A; Weil MT; Weber MS; Nikić I; Potz S; Meinl E; Matznick FE; Kreutzfeldt M; Ghanem A; Conzelmann KK; Metz I; Brück W; Routh M; Simons M; Bishop D; Misgeld T; Kerschensteiner M
    Nat Commun; 2016 Nov; 7():13275. PubMed ID: 27848954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axon loss in multiple sclerosis.
    Scolding N; Franklin R
    Lancet; 1998 Aug; 352(9125):340-1. PubMed ID: 9717917
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
    Jensen SK; Yong VW
    Trends Neurosci; 2016 Jun; 39(6):356-365. PubMed ID: 27113322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroscience: An ageing view of myelin repair.
    Nave KA
    Nature; 2008 Sep; 455(7212):478-9. PubMed ID: 18818646
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
    Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of multiple sclerosis.
    Seitelberger F
    Ann Clin Res; 1973 Oct; 5(5):337-44. PubMed ID: 4792208
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of demyelinating disease.
    Scolding NJ; Zajicek JP; Wood N; Compston DA
    Prog Neurobiol; 1994 Jun; 43(2):143-73. PubMed ID: 7972853
    [No Abstract]   [Full Text] [Related]  

  • 12. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental patterns related to multiple sclerosis pathology.
    Macchi G
    Riv Neurol; 1987; 57(3):145-53. PubMed ID: 3313666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced demyelination: from animal models to human diseases.
    Rose JW
    Mayo Clin Proc; 1992 Sep; 67(9):903-6. PubMed ID: 1434936
    [No Abstract]   [Full Text] [Related]  

  • 17. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord.
    Rodriguez M; Lennon VA; Benveniste EN; Merrill JE
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):84-95. PubMed ID: 2432195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
    Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
    Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M; Armstrong R
    Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.